Thomas Edward Hamilton has bought stock on 7 days since May 2019

Thomas Edward Hamilton is a Director of Larimar Therapeutics, Inc., a pharmaceutical company specializing in therapeutic preparations( He serves as President, Chief Executive Officer, and owner of Construction Forms, Inc. (Con Forms), an industrial manufacturing company based in Port Washington, Wisconsin( Hamilton is also a managing member of FA Life Sciences, an early-stage biotech investment company focused on advancing treatments for Friedreich's ataxia, and serves as a Director and Executive Committee member of the Friedreich's Ataxia Research Alliance (FARA)( Additionally, he is Co-founder of the CureFA Foundation, a nonprofit research organization dedicated to developing a cure for Friedreich's Ataxia(

Hamilton brings extensive financial expertise from his career in capital markets, having served as a managing director and strategic advisor to the head of fixed income, currencies, and commodities at Barclays Capital in New York, where he led the development of Global Securitized Products businesses, Municipal Trading, and Investment Banking( Prior to Barclays, he held positions at Citigroup Global Markets and began his career at Salomon Brothers, Inc. in New York( As of February 2026, Hamilton owns 664,798 shares of Larimar Therapeutics directly and holds an additional 159,433 shares indirectly through Post Edison, LLC, demonstrating significant commitment to the company's success(

Written by Perplexity from public sources.